Combinatorial technology company Symyx Technologies reports today
that revenue for 2002 had increased to $64.8 million (€59m)
compared with $60.0 million in 2001.
US Pharmacopeia has entered into a research collaboration focused
on inflammation with Celgene Corporation. The companies will work
together to identify promising small molecule lead compounds
suitable for further development.
Large Scale Biology Corporation (LSBC) has started a research
collaboration with Novozymes Biotech to apply LSBC's gene shuffling
and molecular evolution technologies to genes of interest to
Novozymes Biotech.
The chemical cousin of vitamin A is thought to restore production
of a key protein, which has been damaged by cigarettes in the lungs
of former smokers, and protects the cells against lung cancer,
according to new findings published...
Two suppliers to the life sciences industry, Amersham Biosciences
and Thermo Electron are to jointly market and sell mass
spectrometry-based proteomics solutions for protein scientists.
Genicon Sciences this week launched its second Resonance Light
Scattering (RLS) technology product - an RLS-based two-colour
nucleic Acid microarray toolkit for gene expression analysis.
Genetronics Biomedical has completed the sale its BTX division to
Harvard Bioscience for $3.7 million. Genetronics Biomedical's
stockholders approved the sale in a meeting on Friday.
High Content Screening company Cellomics announced today that the
Canadian Intellectual Property Office has issued Cellomics'
Canadian Patent No. 2,328,194 entitled 'A System for Cell-Based
Screening.'
In relation to recent media comments relating to its
commercialisation discussions UK company GW Pharmaceuticals said in
a statement this week that it has consistently stated its
commercial strategy 'to be to enter into partnerships...
The structure of a key energy-releasing enzyme found in all animals
is designed to minimise free radical production, an international
team of researchers report in this week's Science.
German LION bioscience has launched an integration platform that
aims to speed up drug discovery by integrating cross-functional
information from a variety of databases and applications
Canadian drug development company Ecopia BioSciences on Monday
announced that it had filed patent applications for the first two
novel compounds using its proprietary drug discovery platform -
suggesting investments by the company...
US company Molecular Devices, a supplier of bioanalytical
measurement systems, announced its revenues and earnings for the
quarter and year ended 31 December, 2002. Revenues for the fourth
quarter of 2002 were a healthy $30.2 million,...
